2000
DOI: 10.1001/archderm.136.7.881
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous Involvement in Patients With Angioimmunoblastic Lymphadenopathy With Dysproteinemia<subtitle>A Clinical, Immunohistological, and Molecular Analysis</subtitle>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
102
1
10

Year Published

2004
2004
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 104 publications
(116 citation statements)
references
References 30 publications
3
102
1
10
Order By: Relevance
“…However, a wide range of skin lesions has been described including papules, plaques, nodules, erosions, urticarial or purpuric eruptions or diffuse erythema [5][6][7][8] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, a wide range of skin lesions has been described including papules, plaques, nodules, erosions, urticarial or purpuric eruptions or diffuse erythema [5][6][7][8] .…”
Section: Discussionmentioning
confidence: 99%
“…In previous reports, skin lesions occurred in 40% to 50% of AITL cases, but the skin pathology was reported to be merely nonspecific [5][6][7][8] . Because of the rarity of AITL and the near absence of skin biopsies, the skin lesions have not been clarified in the dermatologic literature 7,8 .…”
Section: Introductionmentioning
confidence: 91%
“…15,[20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35] Clinically, primary cutaneous CD4( þ ) small/ medium-sized pleomorphic T-cell lymphoma and angioimmunoblastic T-cell lymphoma present or may present with primary cutaneous involvement. 20,[36][37][38][39][40] Other CD4( þ ) T-cell lymphomas with primary cutaneous manifestations include mycosis fungoides and its variants including Sezary syndrome, adult T-cell leukemia/lymphoma and primary cutaneous CD30 þ lymphoproliferative disorders. 41 CD10 has not been reported to be a feature of mycosis fungoides or Sezary syndrome.…”
mentioning
confidence: 99%
“…20,34 Angioimmunoblastic T-cell lymphoma is an aggressive nodal-based disease that involves skin in roughly 50% of individuals. [38][39][40] The neoplastic T cells in angioimmunoblastic T-cell lymphoma express the follicular center helper T-cell markers CD10, PD-1, and CXCL-13 in the majority of cases. 27,[41][42][43] Angioimmunoblastic T-cell lymphoma is also notable for an association with EBV as 70% or more angioimmunoblastic T-cell lymphoma lesions contain EBV( þ ) B cells, a finding helpful in establishing the diagnosis.…”
mentioning
confidence: 99%
“…54,55 However, angioimmunoblastic T-cell lymphoma often presents as a diffuse, pruritic, maculopapular eruption and shows a perivascular infiltrate, vascular proliferation, and/or vasculitis on biopsy, 53,55 features that are not typical of PC-SMTCL. In addition, angioimmunoblastic Tcell lymphoma may include Epstein-Barr virus-positive cells 53,55 and commonly expresses CD10, including in extranodal sites. 53 Finally, patients with angioimmunoblastic T-cell lymphoma have evidence of systemic disease and typically follow an aggressive course with a 5-year survival less than 30%.…”
mentioning
confidence: 99%